Dr. Scapin to continue her leadership and advancement of Garuda’s platform technology for generating self-renewing blood stem cells
CAMBRIDGE, Mass. July 12, 2023 – Garuda Therapeutics announced the appointment of Giorgia Scapin, Ph.D., as Chief Scientific Officer. Transitioning from her previous role as Senior Vice President of Research and Development at Garuda, Dr. Scapin will oversee the company’s scientific strategy and lead the advancement of Garuda’s off-the-shelf hematopoietic stem cell (HSC) therapies in her new role as Chief Scientific Officer. read more →